The Technical Analyst
Yield10 Bioscience Inc [YTEN]
Exchange: NASDAQ Sector: Basic Materials Industry: Agricultural Inputs
Yield10 Bioscience Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
1.83% $0.273
America/New_York / 19 apr 2024 @ 12:19
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 4.20 mill |
| EPS: | -1.820 |
| P/E: | -0.150 |
| Earnings Date: | May 08, 2024 |
| SharesOutstanding: | 15.40 mill |
| Avg Daily Volume: | 5.10 mill |
| RATING 2024-04-19 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Sell | |
| P/E: | Buy | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | n/a | ||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.150 | sector: PE -48.27 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -0.150 | industry: PE -5.53 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.205 - 0.341 ( +/- 24.94%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-28 | Van Nostrand Robert L | Buy | 11 924 | Common Stock |
| 2024-03-28 | Sinskey Anthony J | Buy | 20 561 | Common Stock |
| 2024-03-28 | Hamilton Richard William | Buy | 41 118 | Common Stock |
| 2024-02-15 | Snell Kristi | Buy | 120 000 | Common Stock |
| 2024-02-15 | Haaser Charles B | Buy | 100 000 | Common Stock |
| INSIDER POWER |
|---|
| 82.21 |
| Last 100 transactions |
| Buy: 3 087 669 | Sell: 417 073 |
Forecast:
13:58 - $0.267
Live Trading Signals (every 1 min)
Forecast
1: 12:28 - $0.264
Forecast 2: 13:18 - $0.266
Forecast 3: 13:58 - $0.267
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.273 (1.83% ) |
| Volume | 0.100 mill |
| Avg. Vol. | 5.10 mill |
| % of Avg. Vol | 1.961 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For YTEN
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
YTEN
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.
Latest Press Releases
2024-04-01 16:01:00 - Press Release
Yield10 Bioscience Announces Fourth Quarter And Full Year 2023 Financial Results
-granted global commercial license to vision bioenergy for camelina addressing the biofuel market -advanced regulatory and seed scale-up program for omega-3 camelina -e3902 oil trait in camelina cleared by regulatory authority for planting in canada -management will host a conference call today at 4:30 p.m. (et) to review financial results and provide a corporate update
2024-03-28 16:01:00 - Press Release
Yield10 Bioscience To Announce Fourth Quarter And Full Year 2023 Financial Results And Host A Conference Call On Monday, April 1, 2024
Woburn, mass., march 28, 2024 (globe newswire) -- yield10 bioscience, inc. (nasdaq:yten) (“yield10” or the “company”), an agricultural bioscience company, today announced that the company will report its fourth quarter and full year 2023 financial results and provide a corporate update on monday, april 1, 2024.
2024-03-26 08:29:00 - Press Release
Yield10 Bioscience Announces That The Plant Biosafety Office Of The Canadian Food Inspection Agency Has Cleared Genome-edited E3902 Camelina For Planting In Canada
Woburn, mass., march 26, 2024 (globe newswire) -- yield10 bioscience, inc. (nasdaq:yten) (“yield10” or the “company”), an agricultural bioscience company, today reported that the plant biosafety office (“pbo”) of the canadian food inspection agency (“cfia”) recently reviewed information on the company's e3902 camelina sativa (“camelina”) and determined that e3902 is not a plant with novel trait (pnt) and is not subject to a pre-market notification under part v of the seeds regulations. yield10's e3902 camelina combines genome edits in three proprietary genetic traits, c3008a, c3008b and c3009, that result in an increase in oil production by five percent and produce a lighter seed coat color as compared to the parental camelina line...
2024-03-21 08:29:00 - Press Release
Usda-aphis Determines That Yield10 Bioscience's Omega-3 Camelina Varieties may Be Planted And Bred In The United States
Yield10 bioscience achieves significant milestone enabling ramp-up to commercial scale production of omega-3 fatty acids in camelina in the united states.
2024-02-29 08:31:00 - Press Release
Yield10 Bioscience Reports That Proprietary Varieties Of Winter Camelina Show Tolerance To Commonly Used Herbicides In First Field Tests
-herbicide tolerance is critical to planting the camelina crop on large acreage for the biofuel and omega-3 oil markets -herbicide tolerance is critical to planting the camelina crop on large acreage for the biofuel and omega-3 oil markets
Latest News
2024-04-01 23:05:25 - Seeking Alpha
Yield10 Bioscience, Inc. (YTEN) Q4 2023 Earnings Call Transcript
2024-03-28 16:01:00 - GlobeNewsWire
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024
WOBURN, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its fourth quarter and full year 2023 financial results and provide a corporate update on Monday, April 1, 2024.
2024-03-21 11:05:29 - InvestorPlace
Why Is Yield10 (YTEN) Stock Up 117% Today?
Yield10 Bioscience (NASDAQ: YTEN ) stock is rocketing higher on Thursday after the agricultural bioscience company got new approval from the Department of Agriculture's (USDA) Biotechnology Regulatory Services (BRS). The big news here is Yield10 Bioscience's Camelina sativa varieties getting approval for breeding and growth in the U.S. This came after the agency determined the genetically modified plants don't fall under regulations 7 CFR part 340.
2024-02-05 07:47:41 - InvestorPlace
Why Is Yield10 Bioscience (YTEN) Stock Up 34% Today?
Yield10 Bioscience (NASDAQ: YTEN ) stock is rocketing higher on Monday despite a lack of news from the U.S. agricultural bioscience company. This rally comes alongside heavy trading of YTEN stock on Monday morning.
2023-11-14 21:57:09 - Seeking Alpha
Yield10 Bioscience, Inc. (YTEN) Q3 2023 Earnings Call Transcript
Yield10 Bioscience, Inc. (NASDAQ:YTEN ) Q3 2023 Earnings Conference Call November 14, 2023 4:30 PM ET Company Participants Lynne Brum - Investor Relations Oliver Peoples - President and Chief Executive Officer Kristi Snell - Vice President, Research and Chief Science Officer Chuck Haaser - Chief Accounting Officer Conference Call Participants Ben Klieve - Lake Street Capital Markets Noel Parks - Tuohy Brothers Operator Hello and welcome to the Third Quarter 2023 Financial Results and Business Update Conference Call for Yield10 Bioscience. [Operator Instructions] As a reminder, this conference call is being recorded.
2023-11-08 08:31:00 - GlobeNewsWire
Yield10 Bioscience to Announce Third Quarter 2023 Financial Results and Host a Conference Call on Tuesday, November 14, 2023
WOBURN, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its third quarter 2023 financial results and provide a corporate update on Tuesday, November 14, 2023.
2023-10-24 08:00:00 - Seeking Alpha
Courage & Conviction Investing On Farmer Bros, Red Robin And Yield10 Bioscience
Focusing on small cap stocks and emphasizing the importance of admitting you're wrong. Farmer Brothers, Red Robin Gourmet Burgers, and Yield10 Bioscience examples of small cap stocks with potential.
2023-09-27 08:30:00 - Seeking Alpha
'Stay Hungry, Stay Foolish' Small Cap Strategies With Courage & Conviction Investing
Courage & Conviction Investing discusses why small cap investors should stay committed and have conviction in their ideas despite market drawdowns. Why he's never been more bullish on Advanced Emissions Solutions.
2023-09-07 08:31:00 - GlobeNewsWire
Yield10 Bioscience to Present at the H.C. Wainwright 25th Annual Global Investment Conference
WOBURN, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that management will participate in the H.C. Wainwright 25th Annual Global Investment Conference being held on September 11-13, 2023, at the Lotte New York Palace Hotel.
2023-08-14 21:20:20 - Seeking Alpha
Yield10 Bioscience, Inc. (YTEN) Q2 2023 Earnings Call Transcript
Yield10 Bioscience, Inc. (NASDAQ:YTEN ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Lynne Brum – Vice President of Planning and Corporate Communications Oli Peoples – Chief Executive Officer Kristi Snell – Vice President of Research and Chief Science Officer Chuck Haaser – Chief Accounting Officer Conference Call Participants Anthony Vendetti – Maxim Group Operator Welcome to the Second Quarter 2023 Financial Results and Business Update Conference Call for Yield10 Bioscience. During the call, participants will be in a listen-only mode.